Shandong Phoenix Pharmaceuticals, Ltd.
Shandong Phoenix Pharmaceuticals, Ltd., a prominent player in the pharmaceutical industry, is headquartered in Shandong Province, China. Founded in 2001, the company has established itself as a leader in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, catering to both domestic and international markets. With a strong focus on research and development, Shandong Phoenix Pharmaceuticals offers a diverse range of products, including antibiotics, anti-cancer agents, and cardiovascular medications. Their commitment to innovation and quality has earned them a solid reputation, positioning them favourably within the competitive landscape of the pharmaceutical sector. Notable achievements include various certifications and partnerships that underscore their dedication to excellence and compliance with global standards.
DitchCarbon Score
How does Shandong Phoenix Pharmaceuticals, Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shandong Phoenix Pharmaceuticals, Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shandong Phoenix Pharmaceuticals, Ltd.'s reported carbon emissions
Shandong Phoenix Pharmaceuticals, Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years, as indicated by the absence of specific figures. Furthermore, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing carbon emissions and setting reduction targets to align with global climate goals. As such, Shandong Phoenix Pharmaceuticals may benefit from developing a comprehensive strategy to measure and reduce its carbon footprint in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shandong Phoenix Pharmaceuticals, Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
